Decrease of pro-angiogenic monocytes predicts clinical response to anti-angiogenic treatment in patients with metastatic renal cell carcinoma (mRCC)
Authors
Oudard, SBenhamouda, N
Escudier, B
Ravel, P
Kothari, D
Mehmud, F
Levionnois, E
Sevin, E
Negrier, S
Barthelemy, P
Berdah, J
Ravaud, A
Sternberg, C
Bono, P
Porta, C
De Giorgi, U
Parikh, O
Hawkins, Robert E
Highley, M
Tartour, E
Decker, T
Wilkie, J
Affiliation
Hopital Europeen Georges Pompidou, Oncology, Paris, FranceIssue Date
2015